Panic attacks are associated with sudden episodes, of emotions of fear and anxiety. It is a type of anxiety disorder, and other anxiety disorder includes generalized anxiety disorder, obsessive-compulsive disorder (OCD), Posttraumatic stress disorder (PTSD), social anxiety disorder, and special phobias.Generally, panic attacks are not life threatening but they can be frightening and significantly affect the quality of life. Symptoms of the panic attack may vary from person to person, and intensity of attack. In general, symptomsincludes sense of danger, intense fear of loss of control or death, hot flashes, chills, chest pain, sweating, and feeling of detachment. Major risk factors for panic attacks are genetics, major stress due to changes in a life, or traumatic event, and certain changes in brain functioning. According to World Health Organization (WHO), females are at higher risk of panic attacks than males. Panic attacks left untreated, further may link to the depression, anxiety disorders, and psychiatric disorder, suicidal thoughts, and substance abuse. Treatment can help to reduce frequency, and intensity of panic attacks to improve the quality of life. Treatment recommended for panic attacks include psychotherapy (talk therapy), and medications. Psychotherapy generally considered as a first choice of the treatment.
Panic attacktreatment market segmented intodrug class, and geography. The drug class market segmented into selective serotonin reuptake inhibitor (SSRI), serotonin norepinephrine reuptake inhibitor (SNRI), and benzodiazepines (BZD). Selectiveserotonin reuptake inhibitor class further segmented into fluoxetine (Prozac), paroxetine (Paxil, Pexeva) and sertraline (Zoloft). Further, serotonin norepinephrine reuptake inhibitor includevenlafaxine hydrochloride (Effexor XR). Benzodiazepines includealprazolam (Niravam, Xanax), chlordiazepoxide (Librium), diazepam (Valium) and lorazepam.However, benzodiazepines can be habit forming hence, generally used for short term basis and consider as a last choice of treatment.SSRI and SNRI are consider as a first line therapy for panic attacks patient hence, hold the largest market share globally. Geographically, panic attack treatment market segmented into North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and Rest of the World (RoW). North America dominates the global panic attack market due to increasing incidence of panic attacks, and more awareness in people related to anxiety disordersand expected to maintain the position during forecast period. However, Asia Pacific market, expected to grow at a faster rate due to changing lifestyle led to increasing stress, and growing facilities to detect anxiety disorders.
Some of the major driving factors driving the panic attack treatment market are increasing incidence rate due to more stressful life, sedentary lifestyle, and presence of strong pipeline. According to the Anxiety and Depression Association of America, anxiety disorders are the most common illness in the U.S. and affecting 18% of population. Additionally, 2.7% of population of all anxiety disorders affected by panic attacks, which is approximately 6 million in the U.S. In the National Comorbidity Survey carried out in 2005, 58% of patients diagnosed with major depression found to have an anxiety disorders; among these patients, the rate of comorbidity with panic disorder was highest. However, poor diagnosis rate as no single diagnosis test is available to detect anxiety disorders, and side effects of medications such as habit forming nature, dry mouth, and nauseacould restraint the market growth. Focusing on emerging countrieswould create an opportunity for a market players.
Some of the key players of the global panic attack treatment market are Abbott Laboratories, Actavis Pharmaceutical Company, Baxter International, Bristol-Myers Squibb, Eli Lilly and Company,F. Hoffmann-La Roche, GlaxoSmithKlinePharmaceuticals Limited, Noven Pharmaceuticals, Inc., Pfizer,Inc., Recordati Rare Diseases, Shionogi and Company, and Sumitomo Dainippon Pharma.
This research report analyzes this market on the basis of its market segments, major geographies, and current market trends. This report provides comprehensive analysis of
- Market growth drivers
- Factors limiting market growth
- Current market trends
- Market structure
- Market projections for upcoming years
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.
Reasons for Buying this Report
- This report provides pin-point analysis for changing competitive dynamics
- It provides a forward looking perspective on different factors driving or restraining market growth
- It provides a six-year forecast assessed on the basis of how the market is predicted to grow
- It helps in understanding the key product segments and their future
- It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
- It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
- It provides distinctive graphics and exemplified SWOT analysis of major market segments
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.